Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;33(1):41-6.
doi: 10.1089/pho.2014.3819.

Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study

Rolando Toyos  1 , William McGill, Dustin Briscoe
Affiliations

Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study

Rolando Toyos et al. Photomed Laser Surg. 2015 Jan.

Abstract

Objective: The purpose of this study was to determine the clinical benefits of intense-pulsed-light therapy for the treatment of dry-eye disease caused by meibomian gland dysfunction (MGD).

Background data: MGD is the leading cause of evaporative dry eye disease. It is currently treated with a range of methods that have been shown to be only somewhat effective, leading to the need for advanced treatment options.

Methods: A retrospective noncomparative interventional case series was conducted with 91 patients presenting with severe dry eye syndrome. Treatment included intense-pulsed-light therapy and gland expression at a single outpatient clinic over a 30-month study. Pre/post tear breakup time data were available for a subset of 78 patients. For all patients, a specially developed technique for the treatment of dry eye syndrome was applied as a series of monthly treatments until there was adequate improvement in dry eye syndrome symptoms by physician judgment, or until patient discontinuation.

Results: Primary outcomes included change in tear breakup time, self-reported patient satisfaction, and adverse events. Physician-judged improvement in dry eye tear breakup time was found for 68 of 78 patients (87%) with seven treatment visits and four maintenance visits on average (medians), and 93% of patients reported post-treatment satisfaction with degree of dry eye syndrome symptoms. Adverse events, most typically redness or swelling, were found for 13% of patients. No serious adverse events were found.

Conclusions: Although preliminary, study results of intense-pulsed-light therapy treatment for dry eye syndrome caused by meibomian gland dysfunction are promising. A multisite clinical trial with a larger sample, treatment comparison groups, and randomized controlled trials is currently underway.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
A pretreatment view from one patient presenting with abnormal lid margin and dry eye disease (DED) symptoms.
<b>FIG. 2.</b>
FIG. 2.
A post-treatment view for the same patient as depicted in Fig. 1.
See this image and copyright information in PMC

References

    1. Nichols K, Foulks G, Bron A, et al. . The International Workshop on Meibomian Gland Dysfunction: Executive Summary. Investigat Ophthalmol Vis Sci 2011;52:1922–1929 - PMC - PubMed
    1. Lemp M, Crews L, Bron A, Foulks G, Sullivan B. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort. Cornea 2012;31:472–478 - PubMed
    1. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea 2008;27:1142–1147 - PubMed
    1. Korb DR, Blackie CA. Restoration of meibomian gland functionality with novel thermodynamic treatment device–A case report. Cornea 2010;29:930–933 - PubMed
    1. Korb DR, Blackie CA. Meibomian gland therapeutic expression: quantifying the applied pressure and the limitation of resulting pain. Eye Contact Lens 2011;37:298–301 - PubMed

Publication types

LinkOut - more resources